CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Glumetinib

谷美替尼 杂质对照品Glumetinib Impurities

30 个杂质条目30 impurity entries

本页汇总 谷美替尼 的 30 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 30 impurity reference standards of Glumetinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

谷美替尼 —— 原料药与杂质对照品Glumetinib — drug substance & impurities

共 31 个条目(含原料药本体)31 items incl. the drug substance
Glumetinib structure
原料药 APIAPI
谷美替尼Glumetinib
Glumetinib
CAS No.1642581-63-2
Chemical FormulaC21H17N9O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 1 structure
1
谷美替尼杂质1Glumetinib Impurity 1
Glumetinib Impurity 1
CAS No.1642582-50-0
Chemical FormulaC24H23N9O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 2 structure
2
谷美替尼杂质2Glumetinib Impurity 2
Glumetinib Impurity 2
CAS No.1642582-87-3
Chemical FormulaC25H24N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 3 structure
3
谷美替尼杂质3Glumetinib Impurity 3
Glumetinib Impurity 3
CAS No.1642894-19-6
Chemical FormulaC25H24N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 4 structure
4
谷美替尼杂质4Glumetinib Impurity 4
Glumetinib Impurity 4
CAS No.1642582-85-1
Chemical FormulaC27H28N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 5 structure
5
谷美替尼杂质5Glumetinib Impurity 5
Glumetinib Impurity 5
CAS No.1642582-92-0
Chemical FormulaC28H30N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 6 structure
6
谷美替尼杂质6Glumetinib Impurity 6
Glumetinib Impurity 6
CAS No.1642582-83-9
Chemical FormulaC30H32N10O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 7 structure
7
谷美替尼杂质7Glumetinib Impurity 7
Glumetinib Impurity 7
CAS No.1642582-23-7
Chemical FormulaC30H32N10O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 8 structure
8
谷美替尼杂质8Glumetinib Impurity 8
Glumetinib Impurity 8
CAS No.1642582-88-4
Chemical FormulaC30H32N10O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 9 structure
9
谷美替尼杂质9Glumetinib Impurity 9
Glumetinib Impurity 9
CAS No.1642582-15-7
Chemical FormulaC39H47N11O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 10 structure
10
谷美替尼杂质10Glumetinib Impurity 10
Glumetinib Impurity 10
CAS No.1642583-16-1
Chemical FormulaC7H4Cl2N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 11 structure
11
谷美替尼杂质11Glumetinib Impurity 11
Glumetinib Impurity 11
CAS No.1642583-00-3
Chemical FormulaC10H9N5
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 12 structure
12
谷美替尼杂质12Glumetinib Impurity 12
Glumetinib Impurity 12
CAS No.1642581-60-9
Chemical FormulaC17H12ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 13 structure
13
谷美替尼杂质13Glumetinib Impurity 13
Glumetinib Impurity 13
CAS No.1642582-17-9
Chemical FormulaC17H12BrN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 14 structure
14
谷美替尼杂质14Glumetinib Impurity 14
Glumetinib Impurity 14
CAS No.1642582-18-0
Chemical FormulaC23H17N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 15 structure
15
谷美替尼杂质15Glumetinib Impurity 15
Glumetinib Impurity 15
CAS No.1642582-52-2
Chemical FormulaC20H15N9O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 16 structure
16
谷美替尼杂质16Glumetinib Impurity 16
Glumetinib Impurity 16
CAS No.1642582-37-3
Chemical FormulaC24H19N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 17 structure
17
谷美替尼杂质17Glumetinib Impurity 17
Glumetinib Impurity 17
CAS No.1642582-21-5
Chemical FormulaC21H15N9O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 18 structure
18
谷美替尼杂质18Glumetinib Impurity 18
Glumetinib Impurity 18
CAS No.1642582-28-2
Chemical FormulaC23H16FN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 19 structure
19
谷美替尼杂质19Glumetinib Impurity 19
Glumetinib Impurity 19
CAS No.1642582-33-9
Chemical FormulaC23H16FN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 20 structure
20
谷美替尼杂质20Glumetinib Impurity 20
Glumetinib Impurity 20
CAS No.1642582-39-5
Chemical FormulaC24H16N8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 21 structure
21
谷美替尼杂质21Glumetinib Impurity 21
Glumetinib Impurity 21
CAS No.1642582-41-9
Chemical FormulaC23H16ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 22 structure
22
谷美替尼杂质22Glumetinib Impurity 22
Glumetinib Impurity 22
CAS No.1642582-47-5
Chemical FormulaC24H16N8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 23 structure
23
谷美替尼杂质23Glumetinib Impurity 23
Glumetinib Impurity 23
CAS No.1642581-62-1
Chemical FormulaC18H12F3N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 24 structure
24
谷美替尼杂质24Glumetinib Impurity 24
Glumetinib Impurity 24
CAS No.1642582-19-1
Chemical FormulaC21H15N7O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 25 structure
25
谷美替尼杂质25Glumetinib Impurity 25
Glumetinib Impurity 25
CAS No.1642582-36-2
Chemical FormulaC24H19N7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 26 structure
26
谷美替尼杂质26Glumetinib Impurity 26
Glumetinib Impurity 26
CAS No.1642582-32-8
Chemical FormulaC25H22N8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 27 structure
27
谷美替尼杂质27Glumetinib Impurity 27
Glumetinib Impurity 27
CAS No.1642582-46-4
Chemical FormulaC22H15FN8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 29 structure
29
谷美替尼杂质29Glumetinib Impurity 29
Glumetinib Impurity 29
CAS No.1642583-03-6
Chemical FormulaC13H7Br2N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 31 structure
31
谷美替尼杂质31Glumetinib Impurity 31
Glumetinib Impurity 31
CAS No.1642583-01-4
Chemical FormulaC13H8BrN5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glumetinib Impurity 33 structure
33
谷美替尼杂质33Glumetinib Impurity 33
Glumetinib Impurity 33
CAS No.1642583-04-7
Chemical FormulaC17H12BrN7O2S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

谷美替尼 杂质谱研究要点Glumetinib — impurity profiling notes

下面这些是拿到 谷美替尼 的 31 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 31 impurity entries for Glumetinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances